Endpoint definition
↥| Name | CD2_INSITU_SKIN_LOWERLIMB |
|---|---|
| Long name | Carcinoma in situ of skin of lower limb, including hip |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Carcinoma in situ cutis pelvis |
| Name | CD2_INSITU_SKIN_LOWERLIMB |
|---|---|
| Long name | Carcinoma in situ of skin of lower limb, including hip |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Carcinoma in situ cutis pelvis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 167 | 94 | 73 |
| Unadjusted prevalence (%) | 0.08 | 0.08 | 0.08 |
| Mean age at first event (years) | 71.38 | 70.08 | 73.05 |
| Case fatality at 5-years (%) | 2.99 | 3.19 | 2.74 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 2.0 |
| Recurrence at 6 months (%) | 29.34 | 25.53 | 34.25 |
before Carcinoma in situ of skin of lower limb, including hip
after Carcinoma in situ of skin of lower limb, including hip
Loading survival analyses plot…
Loading survival analyses table…